Cutaneous reactions secondary to <scp>COVID</scp>‐19 vaccination-Reference-Cited by-同舟云学术

Cutaneous reactions secondary to COVID‐19 vaccination

Published:2023-08 Issue:8-9 Volume:34 Page:13-18
ISSN:0959-6682
Container-title:Prescriber
language:en
Short-container-title:Prescriber

Author:

Jmor Shilan¹,Yip Vincent²

Affiliation:

1. Dr Shilan Jmor is a ST5 Dermatology Specialty Trainee at the Department of Dermatology, Broadgreen Hospital, Liverpool University Hospitals NHS Foundation Trust

2. Dr Vincent Yip is a Consultant in Dermatology and Clinical Pharmacology in the Department of Dermatology, Broadgreen Hospital, Liverpool University Hospitals NHS Foundation Trust

Abstract

Cutaneous reactions reported following COVID‐19 vaccination range from mild, self‐limiting reactions to much rarer life‐threatening conditions. This article discusses how to recognise these different types of reaction and determine causality, and provides guidance on the benefits and risks of further vaccination.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology (nursing)

Reference44 articles.

1. World Health Organization. WHO Director‐General's remarks at the media briefing on 2019‐nCoV on 11February 2020. February 2020. Available from:https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020

2. Medicines and Healthcare products Regulatory Agency. UK medicines regulator gives approval for first UK COVID‐19 vaccine. December 2020. Available from:https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine

3. Department of Health and Social Care. Oxford University/AstraZeneca vaccine authorised by UK medicines regulator. December 2020. Available from:https://www.gov.uk/government/news/oxford-universityastrazeneca-vaccine-authorised-by-uk-medicines-regulator

4. Medicines and Healthcare products Regulatory Agency. Moderna vaccine becomes third COVID‐19 vaccine approved by UK regulator. January 2021. Available from:https://www.gov.uk/government/news/moderna-vaccine-becomes-third-covid-19-vaccine-approved-by-uk-regulator

5. COVID‐19: Current understanding of its pathophysiology, clinical presentation and treatment;Parasher A.;Postgrad Med J,2021